Publication | Open Access
Adjuvant Probiotics of Lactobacillus salivarius subsp. salicinius AP-32, L. johnsonii MH-68, and Bifidobacterium animalis subsp. lactis CP-9 Attenuate Glycemic Levels and Inflammatory Cytokines in Patients With Type 1 Diabetes Mellitus
91
Citations
28
References
2022
Year
ClinicalTrials.gov, identifier NCT03880760.
| Year | Citations | |
|---|---|---|
Page 1
Page 1